You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser.
Risks & Strengths of Modern Diagnostic & Research Centre IPO
-
sl_ipo_creation_date
- listed
Risks
- Highly regulatory health care sector with frequent changes in policies and processes.
- Reliance on key suppliers for consumables and diagnostic reagents.
- High levels of debt can also affect cash flows.
- Loan agreements that are without security but are repayable on demand may put pressures on
- Operations are vulnerable to risks such as licensing, approval, and/or regulatory risks.
Strengths
- Had an established diagnostic business with operational history since 1985.
- Integrated service provision between pathology and radiology within the same network.
- Presence in various States, with 21 operational centers.
- Broad range of services including high-end imaging and sophisticated pathology panels.
- Patient-centric model incorporating home-based collection systems and electronic report transmission.
